DinutuximabNKTR-255
… a dose of 0.5-1x10e7 cells/animal once every week for 5 weeks. Dinutuximab was administered via IP injection at 15 ug/animal twice a week.…
4articles mentioning drugs
21drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: dinutuximab ×
dinutuximab
This drug is selected. Its supporting articles are shown below.
Articles mentioning dinutuximab
4 articles · page 1 of 1DinutuximabNHSchemotherapy
…pacity). IV/IM SACT involving 206 vials and costing £65,452.20. Dinutuximab, at £7,600 per vial, accounted for the greatest financial loss.…
dinutuximabNKTR-255IL-15 agonistEwing sarcomaES
…dependent cellular cytotoxicity (ADCC) via an anti-GD2 antibody dinutuximab, and improving NK cell persistence and ADCC by an IL-15 agonist…
TemozolomideIrinotecandinutuximabaCD40Neuroblastoma
… relapsed high-risk neuroblastoma includes chemo-immunotherapy: Temozolomide, Irinotecan, and anti-GD2 antibody dinutuximab (TIG). This regi…